Samsung is backing Alzheimer’s disease blood test developer C2N Diagnostics, with $10 million to help scale up its commercial ...

C2N Diagnostics, LLC, a specialty diagnostics company, has received a $10 million investment from Samsung C&T Corporation, Samsung Biologics, Samsung Bioepis, and Samsung Venture Investment ...

The proof-of-concept showed, according to the corporations, how well artificial intelligence may raise network performance ...

St. Louis-based C2N said it will use the funds to scale its clinical laboratory services and Alzheimer's testing capabilities.

According to a lawsuit, a former senior engineer alleged that he was wrongfully dismissed after reporting racial ...

Late last year, Samsung paired with Nvidia to carry out interoperability tests at Samsung Research's lab. The tests used ...